Belatacept‐Based Immunosuppression and Donor‐Specific Antibodies in Lung Transplant: A Multi‐Institutional Retrospective Study
This is the largest cohort to date of LTx patients with DSA who received Belatacept. Belatacept use was associated with a reduction in DSA.
Authors
- Amy Mu
- Vaidehi Kaza (ORCID: https://orcid.org/0000-0003-3578-6077)
- A. Ishaq (ORCID: https://orcid.org/0000-0001-5313-1619)
- C.I. Mederos
- Amir Emtiazjoo
- Cynthia Gries
- Charles M. Miller (ORCID: https://orcid.org/0000-0001-6413-7389)
- Victoria Reams (ORCID: https://orcid.org/0000-0003-0140-7876)
- Pooja Kumar (ORCID: https://orcid.org/0000-0002-0456-5012)
- Moustafa Younis (ORCID: https://orcid.org/0000-0003-4357-1666)
- Fernando Torres (ORCID: https://orcid.org/0000-0002-9587-010X)
- Mindaugas Rackauskas (ORCID: https://orcid.org/0000-0002-2503-3437)
- I. Timofte
- Mohammad Aladaileh
- Srinivas Bollineni
Institutions
- University of Florida (US)
- Southwestern Medical Center (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Clinical Transplantation
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1111/ctr.70415
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00